SEC Comment Letter 0000000000-23-000158 to Journey Medical Corp (DERM)
Journey Medical Corp
Date: Jan. 5, 2023 · CIK: 0001867066 · Accession: 0000000000-23-000158
AI Filing Summary & Sentiment
File numbers found in text: 333-269079
Letter
United States securities and exchange commission logo January 5, 2023 Ramsey Alloush General Counsel Journey Medical Corporation 9237 E Via de Ventura Blvd., Suite 105 Scottsdale, AZ 85258 Re:Journey Medical Corporation Registration Statement on Form S-3 Filed December 30, 2022 File No. 333-269079 Dear Ramsey Alloush: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David S. Wolpa
Show Raw Text
United States securities and exchange commission logo
January 5, 2023
Ramsey Alloush
General Counsel
Journey Medical Corporation
9237 E Via de Ventura Blvd., Suite 105
Scottsdale, AZ 85258
Re:Journey Medical Corporation
Registration Statement on Form S-3
Filed December 30, 2022
File No. 333-269079
Dear Ramsey Alloush:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David S. Wolpa